* Vicarious Surgical Inc RBOT.N RBOT.K is expected
to show no
change in quarterly revenue when it reports results on April 29
for the period ending March 31 2024
*
* LSEG's mean analyst estimate for Vicarious Surgical Inc
is for
a loss of 9 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Vicarious
Surgical Inc is $1.00, above its last closing price of $0.26.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 -0.12 -0.12 -0.06 Beat 52
Sep. 30 2023 -0.13 -0.14 -0.10 Beat 29.8
Jun. 30 2023 -0.15 -0.14 -0.12 Beat 15.8
Mar. 31 2023 -0.13 -0.13 -0.21 Missed -55.6
Dec. -0.18 -0.17 -0.09 Beat 48.1
31 2022
Sep. 30 2022 -0.16 -0.15 -0.20 Missed -29
Jun. 30 2022 -0.14 -0.14 -0.01 Beat 93.1
Mar. 31 2022 -0.14 -0.13 -0.15 Missed -14.3
This summary was machine generated April 26 at 20:08 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)